The increasing prevalence of infectious diseases, driven by both emerging and re-emerging pathogens, presents a significant global health challenge. The efficacy of traditional antimicrobial therapies is declining due to escalating drug resistance, making the search for innovative pharmacological solutions more necessary than ever.
Natural products have been a cornerstone in the discovery of new therapeutic agents for centuries. Compounds derived from plants, marine organisms, and microbial sources provide a rich reservoir of biologically active molecules with unique mechanisms of action. The fusion of ethnopharmacology with advanced screening technologies holds great promise for identifying new candidates for infectious disease therapies.
Nanotechnology brings a revolutionary approach to the diagnosis, treatment, and prevention of infectious diseases. By using nanoparticles and nanocarriers, drug delivery can be enhanced, pharmacokinetics improved, and toxicity reduced. These advancements make nanotechnology a powerful tool in combating infections.
Understanding the interactions between natural products and nanotechnology is essential for developing advanced therapies. This Research Topic seeks to bridge these fields, presenting integrative approaches to overcome the limitations of conventional treatments.
This initiative aims to be a comprehensive resource for the latest advancements and future directions in the pharmacological treatment of infectious diseases. By fostering cross-disciplinary collaborations, we aim to pave the way for the next generation of therapeutics.
This Research Topic welcomes submissions of the following article types: Original Research Articles, Brief Research Reports, Case Reports, Reviews, Mini-reviews, Methods, and General Commentary.
Keywords:
Infectious diseases, antimicrobial resistance, natural products, nanotechnology, drug delivery, targeted therapy, vaccine development, integrative therapy, pharmacological innovation.
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
The increasing prevalence of infectious diseases, driven by both emerging and re-emerging pathogens, presents a significant global health challenge. The efficacy of traditional antimicrobial therapies is declining due to escalating drug resistance, making the search for innovative pharmacological solutions more necessary than ever.
Natural products have been a cornerstone in the discovery of new therapeutic agents for centuries. Compounds derived from plants, marine organisms, and microbial sources provide a rich reservoir of biologically active molecules with unique mechanisms of action. The fusion of ethnopharmacology with advanced screening technologies holds great promise for identifying new candidates for infectious disease therapies.
Nanotechnology brings a revolutionary approach to the diagnosis, treatment, and prevention of infectious diseases. By using nanoparticles and nanocarriers, drug delivery can be enhanced, pharmacokinetics improved, and toxicity reduced. These advancements make nanotechnology a powerful tool in combating infections.
Understanding the interactions between natural products and nanotechnology is essential for developing advanced therapies. This Research Topic seeks to bridge these fields, presenting integrative approaches to overcome the limitations of conventional treatments.
This initiative aims to be a comprehensive resource for the latest advancements and future directions in the pharmacological treatment of infectious diseases. By fostering cross-disciplinary collaborations, we aim to pave the way for the next generation of therapeutics.
This Research Topic welcomes submissions of the following article types: Original Research Articles, Brief Research Reports, Case Reports, Reviews, Mini-reviews, Methods, and General Commentary.
Keywords:
Infectious diseases, antimicrobial resistance, natural products, nanotechnology, drug delivery, targeted therapy, vaccine development, integrative therapy, pharmacological innovation.
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.